Home 2023

Eli Lilly and Company

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial
Drug Discovery

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial

Alex Philippidis -
0
StockWatch: French Raid Shows Little Effect on Nvidia Price
Artificial Intelligence

StockWatch: French Raid Shows Little Effect on Nvidia Price

Alex Philippidis -
0
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Drug Discovery

Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb

Alex Philippidis -
0
Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Alex Philippidis -
0
Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery
Artificial Intelligence

Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery

Alex Philippidis -
0
Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer
Bioprocessing

Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer

John Sterling -
0
Lilly to Acquire DICE for $2.4B, Expanding Immunology Pipeline
Drug Discovery

Lilly to Acquire DICE for $2.4B, Expanding Immunology Pipeline

Alex Philippidis -
1
Variant Bio Turns Focus from Identifying Genomic Variants to Drug Discovery
Drug Discovery

Variant Bio Turns Focus from Identifying Genomic Variants to Drug Discovery

John Sterling -
0
Antibody Shows Promise against Autoimmune Diseases
Drug Discovery

Antibody Shows Promise against Autoimmune Diseases

Christina Jackson -
0
Lilly Subsidiary, Scribe Ink Up-to-$1.5B CRISPR-Based Neuro Collaboration
Genome Editing

Lilly Subsidiary, Scribe Ink Up-to-$1.5B CRISPR-Based Neuro Collaboration

Alex Philippidis -
0
123...6Page 1 of 6
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.